We use cookies so that we can improve the experience for visitors to our websites. This includes cookies that are necessary for the operation of our websites, as well as other cookies used for analytics purposes. We will not use analytical cookies unless you enable them.
For more information about our use of cookies, please refer to our cookie policy.
These cookies allow us to understand how our websites are used, and to improve our websites over time.
Enable analytics cookies:
Save and close
Head, Global Finance Operations
Director, User Services & Security Operations - Information Technology
Commercial Head, Criminal Justice Systems
Making meaningful recovery from addiction humanly possible.
Our Indivior Investor Presentation is available for download
Our Annual Report and Accounts 2024 is available to download
November 3 2025
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
October 30 2025
Indivior Q3 2025 Financial Results
Our 2024 Impact Report is available to download
Accelerate your career by making a difference
Driving development in addressing addiction and behavioural health issues
The latest information on Indivior